Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Terns Pharmaceuticals, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapeutics for non-alcoholic steatohepatitis (NASH) and other liver diseases. The company leverages its expertise in metabolic disorders to advance innovative treatments addressing significant unmet medical needs.